期刊文献+

DADLE联合山莨菪碱对体外循环心肌保护作用的实验研究 被引量:1

An experimental study on the role of DADLE and Anisodine in cardioprotection during cardiopulmonary bypass
下载PDF
导出
摘要 目的通过建立猪体外循环(cardiopulmonary bypass,CPB)心肌缺血再灌注(myocardial ischemia-reperfusion,MI/R)模型观察联合应用δ阿片受体激动剂DADLE和M受体拮抗剂山莨菪碱后的心肌保护作用,以期为临床心肌保护提供理论和实验依据。方法将16只成年家猪随机分为对照组、预处理两组(n=8),常规建立CPB模型,主动脉阻断同时灌注改良St.Thomas停搏液。每组于CPB前、主动脉开放时、CPB结束时、停机后1 h、停机后2 h检测冠状静脉窦血肌钙蛋白(cardiac troperin T,TnT)含量,相应时间点监测左室舒张末期压(LVEDP)和左室内压最大变化速率(±dp/±dtmax),分别于CPB前和停机后2 h取左心室心肌,以作心肌组织ATP含量的测定。并应用透射电镜观察心肌再灌注损伤超微结构的变化。结果和预处理组相比,对照组心功能指标明显下降。对照组的TnT较预处理组明显升高,相反,其ATP含量明显降低。透射电镜下预处理组的心肌超微结构损伤较对照组明显轻微。结论联合应用DADLE和山莨菪碱能产生较好的心肌保护作用。 Objective To study the combined effects of Muscarinic receptor antiagonist Anisodine and δ-opioid receptor agonist DADLE by establishing swine cardiopulmonary bypass(CPB) myocardial ischemia-reperfusion (MI/R) modd, and to provide academic and experimental evidences for clinical cardioprotection. Methods Sixteen adult swine were randomly divided into 2 groups: control group and preconditioninggroup (n = 8). CPB was instituted routinely and the improved St. Thomas cold cardioplegic solution was administered into the root of aorta. Blood samples were taken from coronary sinus before CPB and TnT were measured at the begin- ning of reperfusion, the end of CPB, one hour after CPB and two hours after CPB. LVEDP and ± dp/± dtmax were measured at the same time points. Left ventricular myocardium of specimens were taken before CPB and two hours after CPB to mesure the contents of ATP. And the myocardium ultrastructures were observed by transmission electron microscope. Results Parameters of cardiac function in control group decreased significantly than those in pretreatment group. Conclusion of TnT increased significantly in control group as compared with that in pretreatment group while the values of ATP decreased significantly in control group. Pretreatment group showed slightes injuries in myocardium under transmission electron microscopy than those in control group. Conclusion Combined Anisodine and DADLE shows significant effects on cardioprotection in swine experimental study.
出处 《同济大学学报(医学版)》 CAS 2007年第6期8-11,共4页 Journal of Tongji University(Medical Science)
基金 国家自然科学基金资助项目(30371417)
关键词 阿片受体 M受体 体外循环 缺血再灌注 心肌保护 opioid receptor muscarinic receptor cardiopulmonary bypass ischemic-reperfusion cardioprotection swine
  • 相关文献

参考文献5

  • 1Fryer RM, Hsu AK, Nagase H, et al. Opioid-induced cardioprotection against myocardial infarction and arrhythmias- mitochondrial versus sarcolemmal ATP-sensitive potassium channels [J ]. J Pharmacol Exp Ther , 2000, 294 : 451 - 457.
  • 2Sigg DC, Clies JR, Oeltgen PR. Role of δ-opioid receptor agonists on ingarct size reduction in swine [ J ]. Am J Physiol Circ Physiol, 2002,282 : 1953 - 1960.
  • 3Romano MA, Seymour EM, Traynor JR, et al. Differential effects of opioid peptides on myocardial ischemic tolerance [J] .J Surg Res,2003,21 (1):512-516.
  • 4刘中民,张轶,范慧敏,卢蓉,戴淡宜.东莨菪碱在心肌再灌注损伤中的作用[J].同济大学学报(医学版),2002,23(2):86-89. 被引量:13
  • 5刘中民,忻元峰,范慧敏,卢蓉.老年心肌缺血再灌注损伤中M受体途径的作用[J].中华胸心血管外科杂志,2004,20(5):289-291. 被引量:4

二级参考文献13

  • 1刘中民,朱洪生.乙酰胆碱在心肌再灌注损伤中作用的实验研究[J].中华胸心血管外科杂志,1993,9(1):65-69. 被引量:15
  • 2刘中民,朱洪生,周嘉,张有荣,朱木兰,张敏.心脏自主神经变化与再灌注损伤关系的研究[J].中华胸心血管外科杂志,1995,11(3):169-171. 被引量:7
  • 3Frenzel H, Feimann J. Age-dependent structural change in the myocardium of rats. A quantitative light-and electron-microscopic study on the right and left chamber wall. Mech Ageing, 1984,27:29-41.
  • 4Ehlert FJ. The relationship between muscarinic receptor occupancy and adenylate cyclase inhibition in the rabbit myocardium. Mol Pharmacol, 1985,28:410-421.
  • 5Jurevicius J, Fischmeister R. Acetylcholine inhibits Ca2+ current by actingexclusively at a site proximal to adenylyl cyclase in frog cardiac myocytes. J Physiol,1996,491(Pt 3):669-675.
  • 6Fleming JW, Strawbridge RA, Watanabe AM. Muscarinic receptor regulation of cardiac adenylate cyclase activity. J Mol Cell Cardiol, 1987,19:47-61.
  • 7Mery PF, Abi-Gerges N, Vandecasteele G, et al . Muscarinic regulation of the L-type calcium current in isolated cardiac myocytes. Life Sci, 1997,60(13-14):1113-1120.
  • 8Brady AJ, Warren JB, Poole-Wilson PA, et al. Nitric oxide attenuates cardiac myocyte contraction. Am J Physiol,1993,265(1 Pt 2):H176-182.
  • 9Gandhi A, Yan L, Scholz PM, et al. Cyclic GMP reduces ventricular myocyte stunning after simulated ischemia-reperfusion. Nitric Oxide, 1999,3:473-480.
  • 10Kwan HY, Huang Y, Yao X. Store-operated calcium entry in vascular endothelial cells is inhibited by cGMP via a protein kinase G-dependent mechanism. J Biol Chem, 2000,275:6758-6763.

共引文献14

同被引文献13

  • 1胡丹,黄从新,江洪,李庚山,涂仲凡,毛志福,王志维.慢性心房颤动患者心房肌细胞Kir2.1、Kir3.4和Kv4.3钾通道重构的研究[J].武汉大学学报(医学版),2005,26(2):133-138. 被引量:1
  • 2张标,佟琳,曾晓荣,刘智飞,杨艳,周光纪,张兆强.心房颤动患者心房肌钾电流的研究[J].中国循环杂志,2005,20(6):460-462. 被引量:3
  • 3Burashnikov A, Antzelevitch C. New pharmacological strategies for the treatment of atrial fibrillation [J]. Ann Noninvasive Electrocardiol, 2009,14(3) :290-300.
  • 4Voigt N, Maguy A, Yeh YH, et al, Changes in I K,ACh single-channel activity with atrial tachycardia remodelling in canine atrial cardiomyocytes[J]. Cardiovas Res,2008, 77(1) :35-43.
  • 5Cha TJ, Ehrlich JR, Chartier D, et al. Kir3-based inward rectifier potassium current: Potential role in atrial tachycardia remodeling effects on atrial repolarization and arrhythmias [J].Circulation,2006,113 (14):1730- 1737.
  • 6Burashnikov A, Antzelevitch C. Atrial-selective sodium channel blockers:do they exist? [J]. J Cardiovasc Pharmacol,2008,52(2) : 121-128.
  • 7Michael G, Xiao L, Qi XY, et al. Remodelling of cardiac repolarization:how homeostatic responses can lead to arrhythmogenesis[J]. Cardiovasc Res, 2009, 81(3): 491-499.
  • 8Ravens U, Cerbai E. Role of potassium currents in cardiac arrhythmias[J]. Europace,2008,10(10) : 1133-1137.
  • 9Perry CA, Pravetoni M, Teske J A, et al.Predisposition to late-onset obesity in GIRK4 knockout mice [J]. PNAS,2008,105(23) : 8148-8153.
  • 10Xie LH, John SA, Ribalet B, et al. Activation of inwardly rectifying potassium (Kit) channels by phosphatidylinosital-4,5-bisphosphate (PIP2) :interaction with other regulatory ligands [J].Prog Biophys Mol Biol, 2007,94(3) : 320-335.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部